Picture this: framing the stage are two pearlescent clouds which, throughout the performance, gently pulsate with flickering ...

Arcutis Biotherapeutics has returned an impressive +200% YTD, following the successful product launch of Zoryve. See why I rate ARQT stock as a Strong Buy.